Prospective comparison of image quality and diagnostic accuracy of 0.5 molar gadobenate dimeglumine and 1.0 molar gadobutrol in contrast-enhanced run-off magnetic resonance angiography of the lower extremities

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 5, 2010, Pages 1166-1171

  Achenbach, Marina ^a   Figiel, Jens H ^a   Burbelko, Mykhaylo ^a   Heverhagen, Johannes T ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

comparative study; contrast agents; magnetic resonance angiography; peripheral arterial occlusive disease; prospective

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADOLINIUM;

ADULT; AGED; ARTICLE; ARTIFACT; BODY WEIGHT; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMAGE QUALITY; INFORMED CONSENT; INTERMETHOD COMPARISON; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; SIGNAL INTENSITY; SIGNAL NOISE RATIO; SINGLE DRUG DOSE;

AGED; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; DOUBLE-BLIND METHOD; FEMALE; GADOLINIUM DTPA; HUMANS; LOWER EXTREMITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL ARTERIAL DISEASE;

EID: 78349279255     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22355     Document Type: Article

References (25)

1. Wang Y, Chen CZ, Chabra SG, et al. Bolus arterial-venous transit in the lower extremity and venous contamination in bolus chase three-dimensional magnetic resonance angiography. Invest Radiol 2002; 37: 458-463.
2. Prince MR, Chabra SG, Watts R, et al. Contrast material travel times in patients undergoing peripheral MR angiography. Radiology 2002; 224: 55-61.
3. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A., Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003; 227: 261-269.
4. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003; 17: 694-702.
5. Kreitner KF, Schmitt R., MultiHance-enhanced MR angiography of the peripheral run-off vessels in patients with diabetes. Eur Radiol 2007; 17 (Suppl 6): F63-F68.
6. Balzer JO, Loewe C, Davis K, etal. Safety of contrast-enhanced MR angiography employing gadobutrol 1.0 M as contrast material. Eur Radiol 2003; 13: 2067-2074.
7. Hentsch A, Aschauer MA, Balzer JO, et al. Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography. Eur Radiol 2003; 13: 2103-2114.
8. Szucs-Farkas Z, Froehlich JM, Ulrich M, et al. 1.0-M gadobutrol versus 0.5-M gadoterate for peripheral magnetic resonance angiography: a prospective randomized controlled clinical trial. J Magn Reson Imaging 2008; 27: 1399-1405.
9. Laurent S, Elst LV, Muller RN., Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006; 1: 128-137.
10. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ., Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724.
11. Tatli S, Lipton MJ, Davison BD, Skorstad RB, Yucel EK., From the RSNA refresher courses: MR imaging of aortic and peripheral vascular disease. Radiographics 2003; 23 (Spec No): S59-S78.
12. Du J, Carroll TJ, Brodsky E, et al. Contrast-enhanced peripheral magnetic resonance angiography using time-resolved vastly undersampled isotropic projection reconstruction. J Magn Reson Imaging 2004; 20: 894-900.
13. Nael K, Fenchel M, Krishnam M, Laub G, Finn JP, Ruehm SG,. High-spatial-resolution whole-body MR angiography with high-acceleration parallel acquisition and 32-channel 3.0-T unit: initial experience. Radiology 2007; 242: 865-872.
14. Ersoy H, Rybicki FJ., MR angiography of the lower extremities. AJR Am J Roentgenol 2008; 190: 1675-1684.
15. Cornfeld D, Mojibian H., Clinical uses of time-resolved imaging in the body and peripheral vascular system. AJR Am J Roentgenol 2009; 193: W546-W557.
16. Haider CR, Glockner JF, Stanson AW, Riederer SJ., Peripheral vasculature: high-temporal- and high-spatial-resolution three-dimensional contrast-enhanced MR angiography. Radiology 2009; 253: 831-843.
17. Kramer H, Nikolaou K, Sommer W, Reiser MF, Herrmann KA., Peripheral MR angiography. Magn Reson Imaging Clin N Am 2009; 17: 91-100.
18. Heverhagen JT., Noise measurement and estimation in MR imaging experiments. Radiology 2007; 245: 638-639.
19. Constantinides CD, Atalar E, McVeigh ER., Signal-to-noise measurements in magnitude images from NMR phased arrays. Magn Reson Med 1997; 38: 852-857.
20. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM., The NMR phased array. Magn Reson Med 1990; 16: 192-225.
21. Reeder SB, Yu H, Johnson JW, et al. T1-and T2-weighted fast spin-echo imaging of the brachial plexus and cervical spine with IDEAL water-fat separation. J Magn Reson Imaging 2006; 24: 825-832.
22. Attenberger UI, Michaely HJ, Wintersperger BJ, et al. Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T. Eur Radiol 2008; 18: 1260-1268.
23. Herborn CU, Lauenstein TC, Ruehm SG, Bosk S, Debatin JF, Goyen M., Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography. Invest Radiol 2003; 38: 27-33.
24. Essig M, Lodemann KP, Le-Huu M, Bruning R, Kirchin M, Reith W,. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T. Invest Radiol 2006; 41: 256-263.
25. Heverhagen JT, Wright CL, Schmalbrock P, Knopp MV., Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA. Eur Radiol 2009; 19: 67-72.